MARIMED (MRMD) COO logs 65,000 RSU conversion and tax share withholding

Rhea-AI Filing Summary

MARIMED INC. Chief Operating Officer Timothy Shaw reported equity compensation activity involving restricted stock units (RSUs) and common shares. On March 1, 2026, 65,000 RSUs were exercised, converting on a one-for-one basis into 65,000 shares of common stock at a stated price of $0.0000 per share.

To cover tax withholding obligations tied to this RSU vesting, 22,523 shares of common stock were withheld by the company at $0.0848 per share, reducing the net shares retained. After these transactions, Shaw directly held 9,337,018 shares of MARIMED common stock.

The filing also notes 2,000,000 shares of common stock held indirectly by the Shaw Family Trust. Shaw’s spouse is the trustee, and the trust benefits their children; Shaw disclaims beneficial ownership of these trust-held securities. The RSUs involved were granted on September 1, 2023, with remaining units scheduled to vest on September 1, 2026 under an award agreement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaw Timothy

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	03/01/2026		M		65,000	A	$0(1)	9,359,541	D
Common stock	03/01/2026		F		22,523(2)	D	$0.0848	9,337,018	D
Common stock								2,000,000	I	By the Shaw Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	03/01/2026		M			65,000	(4)	(4)	Common Stock, par value $.001 per share	65,000	$0	65,000	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. These RSUs were granted on September 1, 2023; the remaining RSUs under this grant will vest on September 1, 2026 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Timothy Shaw	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity transactions did MARIMED INC. (MRMD) report for Timothy Shaw?

Timothy Shaw reported exercising 65,000 restricted stock units into 65,000 MARIMED common shares, with 22,523 shares withheld to cover tax obligations. Following these compensation-related transactions, he directly held 9,337,018 common shares, reflecting routine RSU vesting and associated tax withholding.

How many MARIMED (MRMD) shares does Timothy Shaw hold after the latest Form 4?

After the reported transactions, Timothy Shaw directly holds 9,337,018 MARIMED common shares. An additional 2,000,000 shares are held indirectly by the Shaw Family Trust for his children, where his spouse is trustee and he disclaims beneficial ownership of those trust-held securities.

Were any MARIMED (MRMD) shares sold on the open market in this Form 4?

The Form 4 shows no open-market sales. Instead, 22,523 shares of common stock were withheld by MARIMED to satisfy tax withholding obligations related to RSU vesting, a common administrative disposition, rather than a discretionary market sale by Timothy Shaw.

What are the terms of Timothy Shaw’s MARIMED (MRMD) RSU grant mentioned in the filing?

The RSUs were granted on September 1, 2023 and convert to common stock on a one-for-one basis. The filing states that remaining RSUs from this grant will vest on September 1, 2026 under an existing award agreement between MARIMED and Timothy Shaw.

How is the Shaw Family Trust involved with MARIMED (MRMD) shares on this Form 4?

The filing reports 2,000,000 MARIMED common shares held indirectly by the Shaw Family Trust. Shaw’s spouse serves as trustee, the beneficiaries are their children, and Timothy Shaw expressly disclaims beneficial ownership of these trust-held shares for Section 16 and other legal purposes.